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Chromium is a transition element occurring
in the environment (soil, rocks, plants, dust,
and gases), primarily in the elemental, triva-
lent [Cr(III)], and hexavalent [Cr(VI)] oxida-
tion states. Both Cr(III) and Cr(VI) are
environmentally stable, and their toxicologic
profiles are well known; Cr(III) has limited
toxicologic properties [De Flora et al. 1990;
International Agency for Research on Cancer
(IARC) 1990] and is considered to be an
essential trace metal in humans (Anderson
1981), whereas various Cr(VI) compounds are
considered to be human carcinogens [Agency
for Toxic Substances and Disease Registry
(ATSDR) 2000; De Flora 2000; Ding and
Shi 2002; IARC 1990; Kawanishi et al. 2002;
O’Brien et al. 2003], are known to induce
both acute and chronic toxic effects (ATSDR
2000), and are of the greatest occupational
and environmental health concern.
The respiratory tract is the main target
organ of Cr(VI) toxicity associated with both
acute (short-term) and chronic (long-term)
inhalation (ATSDR 2000; De Flora 2000):
acute exposure may cause shortness of breath,
coughing, and wheezing (Sobaszek et al.
2000). Chronic exposure leads to ulcerations
and perforations of the nasal septum, chronic
bronchitis, decreased pulmonary function,
pneumonia, and other respiratory effects
(Bradshaw et al. 1998). On the basis of exper-
imental and epidemiologic evidence (De
Flora 2000; Gibb et al. 2000; Luippold et al.
2005; Park et al. 2004), IARC has classified
Cr(VI) as a class 1 carcinogen (recognized
human carcinogen). 
Cr(VI) compounds are used in several
industrial applications (chrome plating, weld-
ing inox steel and other special steels, painting,
leather tanning, and wood preserving).
Occupational exposure mainly occurs by
inhalation, but it may involve the gastro-
intestinal tract and skin (De Flora 2000).
Therefore, the respiratory tract is the primary
target organ for Cr(VI) compounds. Experi-
mental work on the rat showed that lung accu-
mulation of Cr(VI) can be observed even after
intravenous administration (Mutti et al. 1979).
The mechanism of Cr(VI) cytotoxicity is not
completely understood, but several studies
have shown that Cr(VI) compounds induce
oxidative stress, DNA damage, apoptotic cell
death, and altered gene expression (Bagchi
et al. 2002; Wise et al. 2002; Zhitkovich
2005). The reduction in Cr(VI) levels induced
by redox-active enzymes and small molecules
generates intermediate unstable states, such as
Cr(V) or Cr(IV), that may mediate the forma-
tion of free hydroxyl, thiyl, ascorbate, and car-
bon-based radicals (Ding and Shi 2002; Levina
and Lay 2005; O’Brien et al. 2003) that are
capable of damaging macromolecular targets,
such as DNA (Stohs et al. 2001). Interestingly,
although Cr(III) reacts with DNA and pro-
teins, it is unable to cross cell membranes. The
opposite occurs for Cr(VI) species, which do
not react with nucleophilic targets but can
easily cross cell membrane through anion
channels. Once inside the cell, Cr(VI) is
rapidly reduced to the trivalent state, and
Cr(III) then interacts with cell proteins and
DNA (Levina and Lay 2005).
Improved work areas, procedures, and
hygiene measures have minimized occupational
exposure to Cr(VI) compounds and led to a
reduction in traditional adverse effects on the
lung, such as tracheobronchitis or pneumonia;
however, long-term Cr(VI) exposure may still
cause airway disorders, including airway irrita-
tion, sensitization, and lung cancer. Sensitive
tests are therefore needed to evaluate early bio-
chemical changes that occur in the respiratory
tract after Cr(VI) exposure. Furthermore,
because the respiratory tract is the primary
route of exposure to Cr(VI), the quantiﬁcation
of biomarkers of free radical production at the
target organ level could improve the sensitivity
and speciﬁcity of putative biomarkers.
We have recently shown that exhaled
breath condensate (EBC), a ﬂuid formed as a
result of the cooling of expired air, is a suit-
able matrix not only for assessing the bio-
markers of oxidative stress in exposed workers
[malondialdehyde (MDA)] but also for quan-
tifying the levels of some pneumotoxic sub-
stances in the lung, in particular, cobalt
(Goldoni et al. 2004). The synergistic effect
of tungsten to power the lipid peroxidation
caused by cobalt has also been demonstrated
(Goldoni et al. 2004).
The aim of the present study was to investi-
gate Cr levels in the EBC of workers employed
in the chrome-plating industry and to assess
early biochemical changes in the airways by
analyzing EBC biomarkers of oxidative stress,
such as hydrogen peroxide (H2O2) and MDA.
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Chromium is corrosive, cytotoxic, and carcinogenic for humans and can induce acute and chronic
lung tissue toxicity. The aim of this study was to investigate Cr levels in exhaled breath condensate
(EBC) of workers exposed to Cr(VI) and to assess their relationship with biochemical changes in
the airways by analyzing EBC biomarkers of oxidative stress, namely, hydrogen peroxide (H2O2)
and malondialdehyde (MDA). EBC samples were collected from 24 chrome-plating workers
employed in a chrome-plating plant both before and after the Friday work shift and before the
work shift on the following Monday. Cr-EBC levels increased from the beginning (5.3 µg/L) to
the end of Friday (6.4 µg/L) but were considerably lower on Monday morning (2.8 µg/L). A simi-
lar trend was observed for H2O2-EBC levels (which increased from 0.36 µM to 0.59 µM on
Friday and were 0.19 µM on Monday morning) and MDA-EBC levels (which increased from
8.2 nM to 9.7 nM on Friday and were 6.6 nM on Monday). Cr-EBC levels correlated with those
of H2O2-EBC (r = 0.54, p < 0.01) and MDA-EBC (r = 0.59, p < 0.01), as well as with urinary Cr
levels (r = 0.25, p < 0.05). The results of this study demonstrate that EBC is a suitable matrix that
can be used to investigate both Cr levels and biomarkers of free radical production sampling the
epithelial-lining ﬂuid of workers exposed to Cr(VI). Key words: chromium, exhaled breath conden-
sate, hydrogen peroxide, lung, malondialdehyde. Environ Health Perspect 114:542–546 (2006).
doi:10.1289/ehp.8506 available via http://dx.doi.org/ [Online 8 December 2005]Materials and Methods
Subjects. Table 1 shows the demographic and
clinical characteristics of the 24 chrome-plating
workers recruited in the study, each of whom
carried out various tasks during the same work
day. Four of these subjects have a history of
light smoking status (< 10 cigarettes/day, corre-
sponding to < 10 packs/year), but we did not
ﬁnd any differences in exhaled biomarker levels
between smoking and nonsmoking workers.
All of the workforce volunteered to participate
in this study, which took place during paid
work hours. The “healthy worker effect” can-
not be ruled out, owing to preemployment
selection procedures. However, all of these
workers underwent medical health surveillance,
and all were asymptomatic and presumably
healthy. The control group consisted of
25 healthy adult volunteers with no signiﬁcant
history of lung disease and who were not occu-
pationally exposed to Cr. The workers also
exhibited normal spirometric indices and did
not report any signiﬁcant previous or current
respiratory diseases. None of them had any
symptoms of acute respiratory illness during
the 4 weeks preceding the study. We found no
differences between male and female control
subjects for the studied biomarkers.
Study design. Before enrollment, the sub-
jects completed a short questionnaire concern-
ing their current and previous medical history
and underwent a spirometric examination.
The EBC and urine samples of the workers
were assessed three times: a) before the work
shift on Friday (T0); b) at the end of the same
shift, after 8 hr of work (T1); and c) before
exposure on the following Monday (T2). EBC
and urine samples from the controls were col-
lected in our laboratory during a normal work
day, and a subgroup of 10 subjects repeated
the procedures in the ofﬁce area of the work-
place in order to exclude any contamination
by the ofﬁce environmental air.
All of the subjects gave their written
informed consent to the procedures, which
were approved by our local ethics committee.
The biologic material was sampled as described
in the Declaration of Helsinki (World Medical
Association 2002).
Spirometric measurements. Spirometry
was performed using a pneumotachograph
(Koko Spirometer, Sensormedics, Milan,
Italy). Mean forced expiratory volume in
1 sec (FEV1) and forced vital capacity (FVC)
were obtained from the three best acceptable
test values of lung function, as recommended
by the American Thoracic Society (1995).
Environmental measurements. Ambient
monitoring was carried out by personal sam-
plers. Brieﬂy, airborne particulate was collected
on polyvinyl chloride membrane ﬁlters (5.0 μm
porosity, 25 mm diameter) according to
National Institute of Occupational Safety and
Health (NIOSH) protocol 7300 (NIOSH
2003a) at a constant flow of 3 L/min for a
period ranging from 90 to 150 min in the
morning or afternoon of the Friday work shift.
The membranes were weighed in a thermo-
hygrometrically conditioned cabinet using a
precision balance with a sensitivity of 0.01 mg
and dissolved in concentrated hyperpure nitric
acid (70%), and the solution was diluted with
ultrapure water. The analytical blank was
obtained from virgin membranes. Total Cr was
analyzed by means of electrothermal atomic
absorption spectroscopy (ETAAS) with
Zeeman background correction following
UNICHIM (Italian Association for Uniﬁcation
in the Sector of Chemical Industry) method
886 (UNICHIM 1995), and expressed as
micrograms per cubic meter. To validate the
precision and the sensitivity of our method, we
used the standard addition method using a cer-
tiﬁed Cr(VI) standard solution (Fluka, Milan,
Italy). The amount of soluble hexavalent Cr in
the ambient air was estimated following
NIOSH protocol 7703 (NIOSH 2003b) after
air collection using stationary samplers in the
work rooms and ofﬁce of the plant.
Airborne concentrations of total Cr for the
Friday work shift were 8.8 (2.6) μg/m3 [GM
(GSD)] in the morning and 5.0 (2.5) μg/m3 in
the afternoon, and the weighted average was
7.8 (2.3) μg/m3. Workers were significantly
more exposed in the morning (p < 0.05) than
during the afternoon half-shift, whereas there
were no significant differences in the collec-
tion times between morning and afternoon.
Soluble Cr(VI) was about 70% of the total Cr
monitored in the environment (data not
shown); therefore, all measured Cr samples
were below the limit proposed by the American
Conference of Governmental Industrial
Hygienists (ACGIH 1999) for water-soluble
Cr(VI) organic compounds (50 μg/m3).
EBC collection. EBC was collected using a
new portable TURBO-DECCS condenser
(transportable unit for research on biomarkers
obtained from disposable exhaled condensate
collection systems; ItalChill, Parma, Italy;
Figure 1A) specifically designed to collect
EBC in clinical and work settings. The con-
denser has a refrigerating system (TURBO)
that thermostatically controls the working
temperature, and a disposable respiratory sys-
tem (DECCS) that consists of a mouthpiece
connected to a one-way aspiration valve and
(through a tube with a special stopper) an EBC
collection test tube at the end (Figure 1B).
On the basis of preliminary data (not shown),
we chose a condensation temperature of –5°C
(Goldoni et al. 2005), a good compromise
between the yield in terms of volume for
multianalyses and detectable concentrations
of the selected analytes.
The subjects were asked to breathe tidally
through the mouthpiece for 15 min, while sit-
ting comfortably in the workplace ofﬁce where
the level of total Cr was < 0.1 μg/m3 (workers)
or in the laboratory office (controls). They
were instructed to form a complete seal
around the mouthpiece with their mouths,
which had to be kept dry by periodically swal-
lowing excess saliva; they were also asked to
rinse their mouths thoroughly before the
maneuver and every 5 min during the test. To
prevent any contamination from the skin, the
subjects were asked to wash their hands before
EBC and urine collection and to wear dispos-
able latex gloves during the collecting proce-
dures. EBC sample volume was accurately
measured with a calibrated pipette, and sali-
vary contamination was excluded by means of
the colorimetric detection of alpha-amylase
activity (Infinity amylase reagent; Sigma,
Milan, Italy). Moreover, we measured the
levels of Cr in saliva of ﬁve workers and found a
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Table 1. Demographic and clinical data of subjects
participating in this study (mean ± SD).
Chrome-plating
Controls workers
No.of subjects 25 24
Sex (male/female) 13/12 24/0
Age (years) 31.0 ± 6.7 37.7 ± 6.3
Smokers/ex-/nona 0/5/20 4/2/18
FVC (% predicted) 108 ± 10.4 89.8 ± 10.7
FEV1 (% predicted) 103.7 ± 11.4 91.8 ± 12.0
FEV1:FVC 81.9 ± 6.3 83.1 ± 7.5














tubemaximum salivary Cr level of about 10 times
higher than the corresponding EBC value, not
sufficient to justify salivary contamination,
given that the limit of detection (LOD) of the
amylase kit was much lower (between 1/10,000
and 1/5,000) than the amylase activity meas-
ured in saliva. Finally, the EBC samples were
transported in dry ice to the laboratory and
stored at –80°C until analysis.
Analysis of Cr in urine and EBC. Urinary
Cr (Cr-U) was measured by ETAAS and
expressed as a function of creatinine. Urinary
overcorrection was excluded because none of
the subjects presented creatinine levels
< 30 mg/L or > 300 mg/L. The LOD was
0.05 μg/L, and a certiﬁed standard (Fluka) was
repeated every 10 samples.
The ETAAS analysis protocol was applied
to the EBC samples, and the results were con-
firmed by inductively coupled plasma–mass
spectrometry (ICP-MS) in a separate labora-
tory, with an interlaboratory regression coefﬁ-
cient of 0.95 and an average deviation between
samples of about 10% (data not shown). The
LOD was 0.05 μg/L.
H2O2-EBC measurements. H2O2-EBC was
measured as previously described (Corradi et al.
2002) using a commercial kit (Amplex Red
hydrogen peroxide assay kit; Molecular Probes,
Eugene, OR, USA) with an LOD of 0.01 μM.
The analyses were made 2–3 days after EBC
collection. Samples were stored at –80°C up to
3 days at the most (Goldoni et al. 2005).
MDA-EBC measurements. MDA-EBC was
measured by tandem liquid chromatography–
mass spectrometry as previously described by
Andreoli et al. (2003), with an LOD of 1 nM. 
Statistical analysis. The data were analyzed
using SPSS 13.0 (SPSS, Chicago, IL, USA)
and PRISM 3.0 (Graphpad Software, San
Diego, CA, USA). The measured parameters
showed a log-normal distribution (Shapiro-
Wilk test) for all the considered groups of sub-
jects; therefore, the data were log-transformed
for all of the statistical tests, and the results
were expressed as the geometric mean (GM)
and geometric SD (GSD). Median values and
interquartile ranges are also reported. We ana-
lyzed log-transformed data using repeated-
measures analysis of variance (ANOVA)
followed by Tukey’s multiple comparisons or
a paired Student t-test in order to assess the
differences within the workers’ group at differ-
ent times. One-way ANOVA, followed by
Dunnett’s multiple comparisons, was used to
assess the differences between the workers and
controls. Pearson’s r was used to assess the cor-
relations between variables in the log-scale.
The normality is required for all parametric
comparison tests, whereas for tests assessing
differences between repeated measures in
dependent samples, a normal distribution is
required for those differences. A log-transfor-
mation of our data was necessary to satisfy
both the above requirements. Moreover, such a
log-transformation was necessary to limit the
undue inﬂuence of the highest values on the r-
and p-values. A p-value of < 0.05 (two-tailed)
was considered signiﬁcant for all of the tests.
Results
Ambient Cr levels sampled during the after-
noon moderately correlated with Cr-U (r =
0.48, p < 0.05) and Cr-EBC at T1 (r = 0.47,
p < 0.05), as shown in Figure 2.
Table 2 shows the Cr-U and Cr-EBC levels
at the different time points. Compared with the
controls, the exposed workers had higher levels
of both at all of the time points (except for a
few Cr-EBC levels at T2) (p < 0.01). Cr-U lev-
els were higher at T1 than at T0 (p < 0.05) and
T2 (p < 0.01), and the difference between T0
and T2 was also signiﬁcant (p < 0.01). Cr-EBC
levels were higher at T0 and T1 than at T2
(p < 0.05 and p < 0.01, respectively), whereas
no difference was observed between T0 and T1. 
Workers’ H2O2-EBC levels were higher
than those of the controls at T0 (p < 0.05)
and T1 (p < 0.01), and there was a signiﬁcant
difference between T2 and both T0 and T1
(p < 0.05 and p < 0.01, respectively); the dif-
ference between T0 and T1 was not signiﬁcant
(Table 2).
The MDA-EBC levels of workers were not
signiﬁcantly higher than those of the controls
at every time point, although 12 of 24 workers
(whose median of Cr-EBC was 11 μg/L) pre-
sented MDA levels above the 95% conﬁdence
interval (CI) upper limit for controls (10 nM)
at T1. The other workers with MDA-EBC
< 10 nM showed a median of 2.5 μg/L of
Cr-EBC. The only significant difference in
MDA-EBC was between T1 and T2 (p < 0.01,
Table 2). 
All nonparametric tests gave results consis-
tent with those observed using their paramet-
ric counterpart on log-transformed values.
Cr-U and Cr-EBC levels presented a weak-to-
moderate correlation at all time points
(r = 0.25, p < 0.05; Figure 3A). Cr-EBC and
H2O2-EBC correlated closely (r = 0.54,
p < 0.01; Figure 3B), particularly at T1
(r = 0.72, p < 0.01; data not shown); Cr-EBC
also correlated with MDA-EBC (r = 0.59,
p < 0.01; Figure 3C). H2O2 and MDA were
positively correlated with each other (r = 0.49,
p < 0.01; Figure 3D).
There was also a correlation between
H2O2-EBC and Cr-U levels—although it
was lower than the correlation between
Cr-EBC and H2O2-EBC (r = 0.41, p < 0.01;
Figure 3E)—whereas the correlation between
Cr-U and MDA-EBC was not significant
(Figure 3F). The signiﬁcance of all the correla-
tions was confirmed by the Spearman non-
parametric correlation test.
We observed no statistically significant
differences in EBC-collected volumes between
exposed workers (mean ± SD, 1,545 ± 255 μL
at T0, 1,460 ± 270 μL at T1, and 1,570 ±
Caglieri et al.
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Figure 2. Correlations, with linear regression lines and Pearson’s r, between environmental airborne Cr















































Table 2. Cr-U, Cr-EBC, H2O2-EBC, and MDA-EBC levels of controls and of workers at different sampling times.
Cr-U (µg/g creatinine) Cr-EBC (µg/L) H2O2-EBC (µM) MDA-EBC (nM)
Controls
GM (GSD) 0.25 (2.3) 0.28 (2.6) 0.09 (1.6) 6.0 (1.5)
Median (25th–75th percentile) 0.24 (0.09–0.45) 0.25 (0.1–0.44) 0.12 (0.05–0.2) 6.5 (5.0–8.2)
Workers (T0)
GM (GSD) 8.2 (2.1)** 5.3 (2.9)** 0.36 (2.4)* 8.2 (1.5)
Median (25th–75th percentile) 7.9 (6.2–10.8) 7.3 (2.3–9.2) 0.44 (0.22–0.61) 7.7 (6.6–11.5)
Workers (T1)
GM (GSD) 9.4 (2.1)**,#  6.4 (3.4)** 0.59 (2.0)** 9.7 (1.7)
Median (25th–75th percentile) 9.0 (5.6–13.4) 7.8 (2.1–15.2) 0.69 (0.42–0.86) 10.7 (6.9–13.4)
Workers (T2)
GM (GSD) 5.7 (2.2)**,##,†  2.8 (3.2)**,#,†  0.19 (2.6)#,†  6.6 (1.5)† 
Median (25th–75th percentile) 5.6 (3.1–6.7) 4.0 (1.1–6.6) 0.21 (0.09–0.35) 6.8 (5.3–8.0)
*p < 0.05 and **p < 0.01 compared with controls. #p < 0.05 and ##p < 0.01 compared with T0. †p < 0.01 compared with T1. 280 μL at T2) and controls (1,585 ± 240 μL).
The exhaled markers did not correlate with
total condensed volume, and because there
were no statistical differences between the total
EBC volumes at the different time points,
total condensed volume was excluded from
the analysis. The total expired air was not
measured because, as already demonstrated by
Gessner et al. (2001), the total volume of
expired air is highly correlated (r = 0.95) with
the total volume of EBC.
Discussion
Blood and urine are currently used for the bio-
logic monitoring of workers exposed to Cr
(Franchini and Mutti 1988; Mutti et al. 1984,
1985), and thus represent the gold standard
matrices for the assessment of exposure.
However, they provide little information con-
cerning lung levels, which are not necessarily
related to absorbed dose, but are certainly
responsible for local inﬂammation on the respi-
ratory tract. EBC analysis is a novel approach
to biologic monitoring, enabling us to quantify
both internal dose levels of inhaled metals and
to assess epithelial-lining fluid levels of bio-
markers of free radical production. The results
of our study show that EBC is a suitable
medium for assessing biomarkers of inﬂamma-
tion (i.e., oxidative stress) and that it can be
used to investigate lung tissue levels and bio-
markers of effect in workers exposed to Cr(VI).
However, future studies are needed to look at
the quantitative relationship between Cr con-
centration in air and EBC levels as well as the
association with relevant clinical outcome to
assess health effects, such as spirometry, or
methacholine reactivity, and so forth.
Our study was designed to assess biologic
markers at different sampling times in order to
evaluate the consequences of long-term and
daily lung exposure. Cr-EBC and Cr-U levels
were much higher in exposed subjects than in
controls at all time points. Furthermore, the
two variables were only slightly positively cor-
related with each other, such a weak-to-mod-
erate correlation being possibly explained by
the relatively complex kinetics of Cr (long-life
kinetic components inside the body, in partic-
ular after chronic exposure) and the presence
of other absorption routes (e.g., dermal).
Owing to their moderate correlation with
Cr levels in ambient air, both Cr-EBC and
Cr-U can be considered biomarkers of expo-
sure. However, further work is needed for a
full validation of Cr-EBC as a biomarker of
exposure and before this metric can be used
independently to assess exposure or health risk.
Looking at the different correlations
between variables, Cr-U and Cr-EBC levels
seem to provide different information: there
were weak or no correlations between Cr-U
and biomarkers of free radical production,
whereas Cr-EBC concentrations correlated
with higher and signiﬁcant r-values with both
MDA and H2O2 levels in EBC, thus suggest-
ing that they may be more representative of
the lung dose responsible for local free radical
production.
We assessed inﬂammation in the lung after
Cr exposure, relying on biomarkers of oxida-
tive stress, which may be sensitive end points
for evaluating early biochemical changes in the
airways. This approach will probably overcome
the limitations of traditional spirometric tests,
which often indicate late and frequently irre-
versible lung dysfunction.
Analyses of MDA and H2O2 levels in EBC
have shown that they are reliable indices of air-
way oxidative stress (Corradi et al. 2003;
Forteza et al. 2005), and they may be of some
help in assessing and understanding the under-
lying mechanisms of metal-induced carcino-
genesis. Accumulated evidence suggests that
the oxidative stress caused by an imbalance of
cellular free radical generation and anti-
oxidative defense plays an important role in
metal-induced cell responses and carcinogene-
sis (Desoize 2003; Sorensen et al. 2005).
Although MDA and H2O2 levels were in the
normal range after 2 days away from work,
H2O2 levels increased to above-normal values
after a weekly and a daily Cr exposure, whereas
50% of workers (the most exposed) showed
MDA levels higher than the 95% CI upper
limit of control MDA levels at the end of the
work shift. However, we speculate that further
inﬂuencing factors, such as individual suscepti-
bility to Cr, may modify MDA levels. As in the
case of the toxic effect of cigarette smoke on
the lungs, it cannot be excluded that an inter-
mittent and repeated inhaled Cr stimulus may
also be responsible for lung damage. It is worth
noting that the increased H2O2 levels observed
Biomonitoring chromium in exhaled breath condensate
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Figure 3. Correlations between variables, with linear regression lines, Pearson’s r, and significance.
(A) Cr-U versus Cr-EBC (r = 0.25, p < 0.05). (B) Cr-EBC versus H2O2-EBC (r = 0.54, p < 0.01). (C) Cr-EBC ver-
sus MDA-EBC (r = 0.59, p < 0.01). (D)H 2O2-EBC versus MDA-EBC (r = 0.49, p < 0.01). (E) Cr-U versus H2O2-
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in EBC of our workers at the end of a work
day were similar to those reported by Gerritsen
et al. (2005) in chronic obstructive pulmonary
disease patients during exacerbations.
Unlike their H2O2 levels, the workers’
MDA-EBC levels did not increase after a day’s
exposure, which suggests that H2O2 may be a
more sensitive marker of acute lung free radical
production in more highly Cr-exposed workers.
However, MDA-EBC and H2O2-EBC were
positively correlated, thus conﬁrming the idea
that the biologic induction of H2O2 (a marker
of inﬂammatory processes) may increase in vivo
oxidative stress and lipid peroxidation products.
Because there is a good correlation between
Cr levels and airway free radical production
and because many studies have identified
Cr(VI) as the most toxic form of Cr, we are
carrying out further studies on the characteri-
zation of Cr species in EBC samples after
exposure to Cr(VI).
Finally, to explain the interindividual vari-
ability (e.g., workers with an anomalous trend
compared with the average), it should be con-
sidered that different jobs and tasks in a
chrome-plating plant may imply exposure to
different Cr species. Different physicochemical
properties, in terms of valence and solubility,
may imply different kinetic and dynamic
properties, thus accounting for a different
behavior of lining ﬂuid (EBC) compared with
urine, whose Cr content is only justified by
absorption of soluble Cr(VI).
In conclusion, EBC can be considered a
promising medium for investigating both
long-term and recent Cr exposure at target
tissue level and, together with biomarkers of
free radical production, it can provide insights
into the oxidative lung interactions between
pulmonary tissue and pneumotoxic metals
occurring in exposed workers.
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